[Lenalidomide; adverse effects and commercialisation].
Ortega Valín
L
L
del Pozo Ruiz
J J
JJ
Rodríguez Lage
C
C
Ramos Ortega
F
F
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003132:Commerce; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide